One-Year Outcomes of 1 + pro re nata versus 3 + pro re nata Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration

Kei Takayama,Hiroki Kaneko,Tadasu Sugita,Ruka Maruko,Kyoko Hattori,Eimei Ra,Kenichi Kawano,Keiko Kataoka,Yasuki Ito,Hiroko Terasaki

One-Year Outcomes of 1 + pro re nata versus 3 + pro re nata Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration

2017

Kei Takayama
Hiroki Kaneko
Tadasu Sugita
Ruka Maruko
Kyoko Hattori
Eimei Ra
Kenichi Kawano
Keiko Kataoka
Yasuki Ito
Hiroko Terasaki

Purpose: We compared 1-year outcomes of 1 + pro re nata (PRN) versus 3 + PRN of intravitreal aflibercept injection (IAI) for age-related macular degeneration (AMD

Keywords:

Ophthalmology
Pathology
Macular degeneration
Pro re nata
Diabetes mellitus
Aflibercept Injection
Optometry
Vascular endothelial growth factor
Medicine
age related

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations